Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction

Exclusion Criteria

• •Systolic BP \<90 mmHg on admission
• •Hemoglobin (Hgb) \< 8 g/dl
• •Known allergy or intolerance to furosemide or low dose dopamine.
• •Hemodynamically significant arrhythmias including ventricular tachycardia or defibrillator shock within 4 weeks
• •Acute coronary syndrome within 4 weeks
• •Cardiac diagnoses in addition to or other than HFpEF:
• •i. Active myocarditis ii. Hypertrophic obstructive cardiomyopathy iii. Severe valvular disease iv. Restrictive or constrictive cardiomyopathy, including known amyloidosis, sarcoidosis, hemachromatosis v. Complex congenital heart disease vi. Constrictive pericarditis vii. Severe pulmonary hypertension (RVSP ≥ 60), not secondary to HFpEF
• •Non-cardiac pulmonary edema
• •Clinical evidence of digoxin toxicity
• •Received IV vasoactive treatment or ultra-filtration therapy for heart failure since initial presentation
• •Anticipated need for IV vasoactive treatment or ultra-filtration for heart failure during this hospitalization
• •History of temporary or permanent renal replacement therapy or ultrafiltration
• •History of renal artery stenosis \> 50%
• •Need for mechanical hemodynamic support
• •Sepsis
• •Terminal illness (other than HF) with expected survival of less than 1 year
• •Previous adverse reaction to the study drugs
• •Use of IV iodinated contrast material/dye in last 72 hours or planned during hospitalization
• •Enrollment or planned enrollment in another randomized clinical trial during this hospitalization
• •Inability to comply with planned study procedures
• •Pregnancy or nursing mothers